Johnson & Johnson has accepted an offer of about $4 billion from the private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics business.
Marchionne said the merged company will be able to increase production to more than 6 million cars a year, a level he has long said is the minimum for an automaker to compete in the global market.
Beyond games, Zuckerberg said virtual reality headsets might someday be used to enjoy a courtside seat at a basketball game, study in a classroom, consult with a doctor face-to-face or shop in a virtual store. The technology also has social applications, he said.
California-based Fisker planned to build cars at the former General Motors plant, but it filed for bankruptcy protection in November.
Nokia Corp. says the $7.3 billion deal will be delayed until next month because it is still waiting for approval from regulatory authorities in Asia.
Horizon Pharma plans to buy Vidara Therapeutics International in a cash-and-stock deal that will add the immune system disorder drug Actimmune to the specialty drug maker's product portfolio.
The company said it would preserve the Beechcraft, Cessna and Hawker general-aviation brands under Cessna CEO Scott Ernest.
Fruit supply companies Chiquita of the United States and Fyffes of Ireland said Monday they had agreed to merge to create the world's biggest banana supplier.
British consumer goods company Reckitt Benckiser is buying K-Y personal lubricants from U.S. health care giant Johnson & Johnson.
Flush with cash and high stock prices, companies are buying up the competition at levels not seen since the dotcom bubble.
Mattel Inc. has made a friendly takeover offer for Canadian toy maker Mega Brands Inc., which has the world's No. 2 line of construction sets after Lego.
Minerals Technologies Inc. has sweetened its offer to buy out Amcol International Corp. to about $1.38 billion in hopes the minerals and oilfield services company will be persuaded to nix its proposed sale to a French company.
Chip maker RF Micro Devices Inc. and TriQuint Semiconductor Inc. are combining in an all-stock deal valued at about $1.56 billion. The deal announced Monday represents an implied price of $9.73 for each TriQuint share. This is a 5 percent premium to the company's Friday closing price of $9.23.
Eli Lilly is buying a privately held, poultry vaccine maker to strengthen its Elanco animal health subsidiary. No terms were released, but Lilly said Monday that its 2014 earnings forecast will be trimmed due to acquisition costs.
Minority shareholders of Swedish truck maker Scania say they are hesitant about Volkswagen's 6.7 billion-euro ($9.2 billion) offer to take over the rest of the company. Swedish pension fund AP4 said in a statement Monday it will review the offer but that "it is not obvious that the price now offered is best in the long term."
Jack Link’s® announced plans on Friday to purchase Unilever’s® meat snacks business, primarily sold under the BiFi brand (Germany, Benelux, Austria and Switzerland) and the Peperami brand (UK and Ireland). Terms were not disclosed.
Lydall, Inc. (NYSE:LDL), today announced that it has acquired the industrial filtration businesses of Andrew Industries Limited, an Altham, United Kingdom-based corporation, for $83 million in cash. The acquired business consists of operations in the United States, the United Kingdom, and China, and approximately 500 employees.
Toshiba Corp. said Thursday it will spend hundreds of billions of yen by the business year ending March 2018 on mergers and acquisitions to expand its health care business, as part of efforts to make the area a new pillar of its management.
With $158.8 billion in cash on its balance sheet, Apple certainly has the money to buy Tesla, which has a market cap of about $24 billion. Although a pairing of the two companies is a likely long shot and far off at best, it's kind of fun to think about a car made the company that brought us the iPhone and iPad.
Actavis PLC says it will acquire fellow drugmaker Forest Laboratories Inc. in a cash-and-stock deal worth about $25 billion. The deal would create a combined company spanning both generic and branded drugs, including Forest's Alzheimer's treatment Namenda and the antidepressant Lexapro.
The subtle change surfaced this week in Google's 2013 annual report. Google Inc. didn't quantify the total number of deals that it closed last year in the regulatory filing, marking the first time that the U.S. company has withheld that detail since going public in 2004.
While 2013 as a whole marks the second consecutive annual decline, deal activity in the second half of the year increased with 83 deals worth $35.7 billion versus 69 deals for $24 billion in the first half. The fourth quarter of 2013 recorded 40 transactions worth $50 million or more.
Swiss food and drink giant Nestlé and French cosmetics company L'Oréal have approved a deal to transfer ownership of Swiss dermatology pharmaceuticals company Galderma. The companies say L'Oréal will buy 48.5 million of its own shares, or 8 percent of its share capital, from Nestlé and give Nestlé its 50 percent stake in Galderma, which has been a 50/50 joint venture between them.
Microchip Technology is buying mixed signal semiconductor maker Supertex for approximately $246 million, helping to expand the chipmaker's presence in the medical, lighting and industrial markets. Both companies' boards unanimously approved the acquisition. It needs approval from Supertex shareholders.
A bankruptcy judge had rejected Hybrid's plan to use $75 million it claims it is owed as Fisker's senior secured lender on the bid. He capped Hybrid's credit bid at $25 million, setting up a competitive auction with Chinese auto parts conglomerate Wanxiang Group Corp.